LRRK2 and Parkinson disease: However, fibroblasts derived from patients with Parkinson’s disease with the LRRK2 mutation, which are clinically indistinguishable from those of IPD in terms of disease onset and main motor symptoms, showed a different set of mitochondrial morphometric changes than in patients with IPD analysed in the present study, particularly mitochondrial elongation and increased interconnectivity18.